Hypermethylation of C9orf72 is linked to transcriptional repression in ALS/frontotemporal dementia (FTD) patients, potentially serving as a neuroprotective mechanism that mitigates molecular distortions related to hexanucleotide repeat expansions (149). Here, C9orf72 is linked to frontotemporal dementia.